CAS 863029-89-4
:2-{[(4-chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-5-methoxy-1H-benzimidazole
4-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H16ClN3O2SColor and Shape:Off-White SolidMolecular weight:349.065184-Desmethoxy-4-chloro Omeprazole
CAS:Formula:C16H16ClN3O2SPurity:%Color and Shape:SolidMolecular weight:349.8351Omeprazole EP Impurity H
CAS:Formula:C16H16ClN3O2SColor and Shape:Off-White SolidMolecular weight:349.832-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazole
CAS:2-(((4-Chloro-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-5-methoxy-1H-benzo[d]imidazolePurity:95%Molecular weight:349.84g/molOmeprazole EP Impurity H
CAS:Controlled ProductFormula:C16H16ClN3O2SColor and Shape:NeatMolecular weight:349.844-Desmethoxy-4-chloro Omeprazole
CAS:Controlled ProductImpurity Omeprazole EP Impurity H
Applications 4-Desmethoxy-4-chloro Omeprazole (Omeprazole EP Impurity H) is an Impurity D from the synthesis of Omeprazole.
References Kohl, B., et al.: J. Med. Chem., 35, 1049 (1992),Formula:C16H16ClN3O2SColor and Shape:NeatMolecular weight:349.845-Methoxy-2-[[(4-Chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole
CAS:5-Methoxy-2-[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy-1H benzimidazole is a synthetic drug product. It has been used as a positive control in metabolism studies and as an impurity standard. 5-Methoxy 2-[(4-chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfinyl]-5 methoxy 1H benzimidazole is also a metabolite of the active pharmaceutical ingredient (API) which is used to develop drugs. This chemical is synthesized by custom synthesis and can be obtained at high purity levels. The metabolite of this compound is 5 methoxy 2-[(4 chloro 3,5 dimethyl 2 pyridinyl)methyl]sulfonyl]-5 methoxy 1H benzimidazole.
Formula:C16H16ClN3O2SPurity:Min. 95%Color and Shape:PowderMolecular weight:349.84 g/mol








